Evidence map›Paper›PMID 35626218›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Prognostic Value of Perineural Invasion on Survival and Recurrence in Oral Squamous Cell Carcinoma.

Steffen Spoerl, Silvia Spoerl, Stephanie Reil, Michael Gerken, Nils Ludwig, Juergen Taxis, René Fischer, Tobias Ettl, Torsten E Reichert, Gerrit Spanier

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Steffen SpoerlDepartment of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Silvia SpoerlDepartment of Internal Medicine 5-Hematology/Oncology, Friedrich-Alexander University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Stephanie ReilDepartment of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Michael GerkenTumor Center, Institute for Quality Management and Health Services Research, University of Regensburg, 93053 Regensburg, Germany.
Nils LudwigDepartment of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0000-0001-5561-2184
Juergen TaxisDepartment of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0000-0002-9733-3703
René FischerDepartment of Otorhinolaryngology, University Hospital Regensburg, 93053 Regensburg, Germany.
Tobias EttlDepartment of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Torsten E ReichertDepartment of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.
Gerrit SpanierDepartment of Cranio-Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, Germany.ORCID 0000-0002-0226-7580
University Hospital Regensburg · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity of Regensburg · DE

Funding

Else Kröner-Fresenius-Stiftung 3752916
6 · The paper itself

Abstract

A diagnosis of perineural invasion (PNI) is widely accepted as an unfavorable prognostic factor in various solid malignancies. Although PNI has been described as a high-risk parameter in oral squamous cell carcinoma (OSCC), its role in the current staging manuals of the American Joint Committee on Cancer (AJCC) is rather subordinate. We analysed the prognostic value of PNI on survival and recurrence in a large, multicenter OSCC cohort and a population-based approach. A total of 493 OSCC patients with primary tumor resection to negative margins and concomitant neck dissection between 2010 and 2017 were enrolled. PNI was evaluated in relation to overall survival (OAS) and recurrence-free survival (RFS) using uni- and multi-variable Cox regression. The median follow-up time was 5.0 years and PNI was diagnosed in 48 patients (9.7%). A pathohistological verification of PNI correlated significantly with a deteriorated OAS in uni- (HR 2.312; 95% CI 2.312-3.493,

Indexed as

oral canceroral squamous cell carcinomaperineural invasionPNIrecurrencesurvival

Identifiers

PMID35626218
PMCPMC9139854
OpenAlexW4224325087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.